Cyclophosphamide

tumor necrosis factor ; Mus musculus







43 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34949747 Immune-Enhancing Effects of Crude Polysaccharides from Korean Ginseng Berries on Spleens of Mice with Cyclophosphamide-Induced Immunosuppression. 2022 Feb 28 2
2 34128029 Alhagi honey polysaccharides attenuate intestinal injury and immune suppression in cyclophosphamide-induced mice. 2021 Aug 2 1
3 34667205 Lactobacillus rhamnosus and Bifidobacterium longum alleviate colitis and cognitive impairment in mice by regulating IFN-γ to IL-10 and TNF-α to IL-10 expression ratios. 2021 Oct 19 2
4 34840584 The Immunomodulatory Effects of Phellodendri Cortex Polysaccharides on Cyclophosphamide-Induced Immunosuppression in Mice. 2021 1
5 32033362 Protective Effects of Evening Primrose Oil against Cyclophosphamide-Induced Biochemical, Histopathological, and Genotoxic Alterations in Mice. 2020 Feb 5 1
6 32475918 Characterization and Immunological Activities of Polysaccharides from Polygonatum sibiricum. 2020 2
7 31472897 Dendrobium sonia polysaccharide regulates immunity and restores the dysbiosis of the gut microbiota of the cyclophosphamide-induced immunosuppressed mice. 2019 Aug 1
8 28939510 Characterization and protective effect of Polygonatum sibiricum polysaccharide against cyclophosphamide-induced immunosuppression in Balb/c mice. 2018 Feb 1
9 29136560 Cytoprotective effects of glycyrrhetinic acid liposome against cyclophosphamide-induced cystitis through inhibiting inflammatory stress. 2018 Jan 1
10 29936365 S-allyl cysteine ameliorates cyclophosphamide-induced downregulation of urothelial uroplakin IIIa with a concomitant effect on expression and release of CCL11and TNF-α in mice. 2018 Aug 2
11 28527347 Immunostimulatory activity of plumieride an iridoid in augmenting immune system by targeting Th-1 pathway in balb/c mice. 2017 Jul 1
12 26884983 Immuno-enhancement effects of Lycium ruthenicum Murr. polysaccharide on cyclophosphamide-induced immunosuppression in mice. 2015 2
13 26939331 [Effects of acupuncture-moxibustion on contents of IL-12 and TNF-α in spleen of cyclophosphamide- induced cancer-bearing mice]. 2015 Nov 1
14 21649551 Effect of millimeter waves and cyclophosphamide on cytokine regulation. 2012 Feb 1
15 22441388 Modulation of anti-tumor necrosis factor alpha (TNF-α) antibody secretion in mice immunized with TNF-α kinoid. 2012 May 1
16 21279551 Effect of zymosan on antioxidant and immune function of S180 tumor-bearing mice. 2011 Jul 1
17 20208453 Immunomodulatory effects of Aureobasidium pullulans SM-2001 exopolymers on the cyclophosphamide-treated mice. 2010 Feb 1
18 16488414 Cyclophosphamide enhances TNF-alpha-induced apoptotic cell death in murine vascular endothelial cell. 2006 Mar 6 3
19 16622862 Effect of cyclophosphamide and 61.22 GHz millimeter waves on T-cell, B-cell, and macrophage functions. 2006 Sep 2
20 16933209 Differential teratogenic response of TNFalpha+/+ and TNFalpha-/- mice to cyclophosphamide: the possible role of NF-kappaB. 2006 Jun 4
21 15605409 Effect of millimeter waves on natural killer cell activation. 2005 Jan 2
22 15060740 Modulation of thalidomide pharmacokinetics by cyclophosphamide or 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice: the role of tumour necrosis factor. 2004 May 2
23 15274362 Profile of cytokines produced in tumor tissue after administration of cyclophosphamide in a combination therapy with tumor necrosis factor. 2004 May-Jun 1
24 12820293 Effect of millimeter waves on cyclophosphamide induced suppression of T cell functions. 2003 Jul 2
25 12012107 Anti-metastatic activity of hapten-modified autologous tumor cell vaccine in an animal tumor model. 2002 Jun 2
26 9973423 Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. 1999 Feb 1 4
27 9574530 TNF-alpha messenger RNA and protein expression in the uteroplacental unit of mice with pregnancy loss. 1998 May 1 1
28 9854510 Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions. 1998 Sep-Oct 3
29 9066630 Augmentation of antitumor effect of endogenously induced tumor necrosis factor by cyclophosphamide. 1997 Jan-Feb 6
30 9096241 Activation of P388D1 macrophage cell line by chemotherapeutic drugs. 1997 2
31 9344509 Adverse effects of tumour necrosis factor in cyclophosphamide-treated mice subjected to gut-derived Pseudomonas aeruginosa sepsis. 1997 Oct 2
32 8933279 Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates. 1996 Oct 1
33 7627991 Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor alpha combination treatment of EL4-lymphoma-bearing C57BL/6 mice. 1995 Jun 1
34 7749066 Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity. 1995 Jan 1
35 8634684 Participation of TNF-alpha and IL-1 in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. 1995 Oct 1
36 7930875 Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide. 1994 Oct 1
37 7685182 Restoration of the acute phase response after infection in cyclophosphamide-treated mice by granulocyte colony-stimulating factor. 1993 4
38 1290956 The therapeutic potential of interleukin-1 and tumor necrosis factor on hematopoietic stem cells. 1992 Nov 2
39 1398912 Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. 1992 Oct 2
40 2121696 Production and enhanced anti-tumor activity of tumor necrosis factor in mice treated with cyclophosphamide. 1990 Sep 5
41 2736513 Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo. 1989 Jul 15 1
42 2448255 Effect of immunostimulants and antitumor agents on tumor necrosis factor (TNF) production. 1987 3
43 3804497 Anti-tumor effects of tumor necrosis factor in combination with chemotherapeutic agents. 1987 Feb 15 2